Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
Mehdi Hamadani(Medical College of Wisconsin), Mary M. Horowitz(Medical College of Wisconsin), Saurabh Chhabra(Medical College of Wisconsin), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Anita D’Souza, Claudio G. Brunstein(Hotel Dieu Hospital), Filippo Milano(Fred Hutch Cancer Center), Wael Saber(Medical College of Wisconsin), Daniel J. Weisdorf(University of Minnesota), Xiao-Ying Tang(Medical College of Wisconsin), Rachel Phelan(Children's Hospital of Wisconsin), Steven M. Devine(National Marrow Donor Program), Mei-Jie Zhang(Medical College of Wisconsin), Mingwei Fei(Medical College of Wisconsin)
Cited by 60
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
|Journal of Clinical Oncology|2001|682